Atox Bio
Company description
See translation
Atox Bio is a late-stage biotechnology company that develops novel immunomodulators for critically ill patients. The companys lead product, AB103, is initially being developed to treat necrotizing soft tissue infections (NSTI), a rare and life-threatenin...
HS code: {{pas.hsCode | limitTo: 23}}
Commercial information
Affiliations:
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us